Naval Medical Logistics Command, Code 05, Bldg. 521, Ft. Detrick, Frederick, MD 21702-5015

65 -- HAEMONETICS CELL WASHING SYSTEM SOL N62645-96-R-0037. Contact Ralph Payne, Contract Specialist, 301/619-3018, Terry L. Horst, Contracting Officer, 301/619-3012. The Naval Medical Logistics Command has a requirement for blood cell washer systems. The Navy intends to negotiate with Haemonetics Corporation as the only one source. This notice is not a request for competitive proposals. See Note 22. This requirement is a combined synopsis/solicitation for a commercial item prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only Request for Proposal under Solicitation N62645-96-R-0037. The Government contemplates award of a Firm Fixed Price Indefinite Delivery Indefinite Quantity contract. A proposal from Haemonetics Corporation, Braintree, MA, is being requested and a written solicitation will not be issued. Haemonetics shall satisfy this requirement by providing the following Contract Line Items (CLINs); CLIN 0001, Haemonetics Model M115 Cell Washing System, 120/230 volt, 50/60HZ, AC, PN 8818, MIN 5 each, MAX 58 each; CLIN 0002, Cell Wash Set (10/case), PN 7497, MIN 67 each, MAX 1542 each; CLIN 0003, Quad Packs (20/case), P/N 842, MIN 33 each, MAX 918 each; CLIN 0004, Waste Bags (50/case), P/N 5606, MIN 10 each, MAX 155 each. The blood cell washers shall meet the following specifications: SALIENT CHARACTERISTICS * Shall be a blood cell washing system for deglycerolizing thawed red blood cells by a sequential dilution method. Shall be a gravity fed continuous flow type red blood cell washing system suitable for high glycerol freezing protocols. * Shall have a cabinet housing with a pole stand. * Shall be designed to use disposable plastic washbowl/waste bag sets (not required to be supplied with the washing system). * Shall have cabinet housing designed and constructed to include the following: a. A fixed speed centrifuge designed to accommodate an inserted washbowl. The centrifuge shall operate at a nominal speed of 5800 rpm. b. A top mounted oscillating mixing platform with eight (8) adjustable magnetic mounting posts that include mounting pins. The mixing platform shall operate with a nominal oscillation rate of 180 cycles/minute. The magnetic mounting posts shall be adjustable for securing a primary collection bag (i.e. unit containing glycerolized red blood cells) to the mixing platform. c. Electrical controls for activating and deactivating the mixing platform and centrifuge. d. A cooling fan that operates whenever the mixing platform and centrifuge are in operation. e. A 30 minute mechanical timer with audio alarm that is graduated in one (1) minute intervals. The timer shall be used for indicating when a preset time has been reached, without controlling any component of the blood cell washing system. f. Mounting pins that are secured to the side of the housing, for mounting a 3000 mL capacity waste bag that is a component of the washbowl/waste bag set. g. Suitable fittings for supporting an inserted pole stand in an upright position. * Shall be supplied with pole stand with 45 inch minimum height. The pole stand include four (4) height adjustable support hooks that can be used for suspending plastic type IV solution bags. * Shall be suitable for use with a plastic washbowl/waste bag set with the following characteristics: a. Consists of a centrifuge bowl with inlet and outlet port connectors, and integrally attached cell wash harness, and a detachable 3000 mL capacity waste bag. b. The cell wash harness consists of various lengths of plastic tubing, four (4) ``Y'' type connectors, and a four (4) color spike harness (i.e. with a yellow, a blue, and 2 red color coded spike terminations). c. The yellow color spike intended for connection to a 3000 mL capacity container with a 0.9% saline/0.2% dextrose solution. d. The blue color spike intended for connection to a 150 mL capacity container with a 12% saline solution. e. The red color spike intended for connection to two (2) primary collection bags containing glycerolized red blood cells. f. The wash solution perfuses the red blood cells in the spinning washbowl, and then exits separately through the outlet port of the washbowl into the waste bag for disposal. g. The washed unit of red blood cells is siphoned from the washbowl into a blood recovery pack that is suspended from a support hook on the pole stand. FINISH. The unit shall be fabricated from materials which are inherently resistant to corrosion or which are treated to render them corrosion-resistant. Where painting or plating is used, appropriate cleaning and priming shall be performed prior to finishing. Unless otherwise specified, finish shall be equivalent or superior to that of comparable commercial equipment, and shall be free of gaps, scratches, chips, and other imperfections. WORKMANSHIP. The blood cell washer shall be free from defects which detract from its appearance or impair its serviceability. FEDERAL FOOD, DRUG AND COSMETIC ACT. This product is considered a medical device by the US Food and Drug Administration, and the contractor shall comply, and be responsible for compliance by its subcontractors/suppliers, with the requirements of the Federal Food, Drug and Cosmetic Act, as amended, and regulations promulgated thereunder. In addition, the contractor shall comply, and be responsible for compliance by its subcontractors/suppliers, with the requirements of all other applicable federal, state and local statutes, ordinances, and regulations. STANDARDS MANUALS. The contractor shall provide a minimum of two (2) of all standards manuals to include service (wiring diagrams, schematics, and parts list), technical and operational manuals with each unit. This solicitation incorporates provisions and clauses effective through Federal Acquisition Circular Number 90-37. The provision at FAR 52.212-1, Instructions to Offerors-Commercial Items, applies to this acquisition with the exception of (d), (e), (f), (h), and (i) of the clause, which are RESERVED. Proposal evaluation will be based on the technical description of the items offered, to include product literature, or other documents, to determine technical acceptability; and the Government's determination that the proposed price is fair and reasonable. To support the offered price, the offeror shall include copies of published commercial price list, or other documentation setting forth the prices charged to the general public. The Government will award a contract based on; 1) Determination of technical acceptability of items offered, and 2) Determination that the proposed price is fair and reasonable. Haemonetics shall include a complete copy of the provision at FAR 52.212-3, Offeror Representations and Certifications-Commercial Items, with their offer. Additionally, Haemonetics shall include a completed copy of the provision at DFARS 252.212-7000, Offeror Representations and Certifications-Commercial Items. Addenda to this provision includes DFARS 252.225-7000, Buy American Act-Balance of Payments Program Certificate, and 252.225-7006, Buy American Act-Trade Agreements-Balance of Payments Program Certificate. FAR 52.212-4, Contract Terms and Conditions-Commercial Items, applies to this acquisition. FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items, applies to this acquisition. In compliance with said clause, the following additional FAR clauses apply: 52.203-6, Restrictions on Subcontractor Sales to the Government, with Alternate I; 52.203-10, Price or Fee Adjustment for Illegal or Improper Activity; 52.219-8, Utilization of Small business Concerns and Small Disadvantaged Business Concerns; 52.222-26, Equal Opportunity; 52.222-35, Affirmative for Special Disabled and Vietnam Era Veterans; 52.222-36, Affirmative Action for Handicapped Workers; 52.222-37, Employment Reports on Special Disabled Veterans and Veterans of the Vietnam Era. DFARS 252.212-7001, Contract Terms and Conditions Required to Implement Statutes Applicable to Defense Acquisitions of Commercial Items, applies to this acquisition. In compliance with said clause, the following additional DFARS clauses apply: 252.205-7000, Provision of Information to Cooperative Agreement Holders; 252.233-7000, Certification of Claims and Requests for Adjustment or Relief. CLINs shall be ordered by issuance of delivery orders. Such orders may be issued from date of contract award through September 30, 2001, or until the time the Government has placed orders totaling the ``maximum'' quantities. All delivery orders are subject to the terms and conditions of the contract. In the event of conflict between a delivery order and the contract, the contract shall control. The contractor shall furnish to the Government the items specified up to and including the quantity designated at the ``maximum''. The Government shall order at least the quantity of items designated as the ``minimum''. There is no limit on the number of delivery orders that may be issued. The Government may issue orders requiring delivery to multiple locations. All delivery orders shall contain the following information: Date of order; Contract number and order number; Item number(s) and description, quantity, and unit price; Delivery date(s); Place of delivery (including consignee); Packaging, and shipping instructions (if any); Accounting and appropriation data; Payment office and address. Haemonetics proposal is due at Naval Medical Logistics Command by 1:00 PM (local time) August 30, 1996. Point of contact is Ralph Payne, 301/619-3018. (218)

Loren Data Corp. http://www.ld.com (SYN# 0403 19960807\65-0001.SOL)